title: [Initial selectivity of the antiplatelet covalent action of biogenic chloramines on platelet-rich plasma].
abstract: To describe in full the peculiarities of the antiplatelet action of covalent inhibitors on platelet-rich plasma, we have proposed to take into account the initial selectivity that determines the elevated efficacy of inactivation of platelet molecular target (receptor). The quantitative index of initial selectivity is the ratio of rate constant of inactivation of the platelet molecular target to the rate constant of the chemical reaction of an inhibitor with reactive atomic groups in plasma proteins. For the important case of the domination of the inhibitor expenditure in the reaction with plasma proteins, a formula was derived which depicts the dependence of the share of inactivated targets on the concentration of the inhibitor introduced and reactive atomic groups contained in plasma. In the case of chloramine derivatives of amino acids, evidence was obtained indicating that the degree of inhibition of platelet aggregation measured by the turbidimetric method is equal to the square of the share of inactivated receptors. The index of initial selectivity can be evaluated by measuring the degree of inhibition of platelet aggregation and the operating concentration of the inhibitor. According to experimental evidence, the effects of a number of chloramine derivatives of amino acids (biochloramines) on aggregation of platelets stimulated by ADP show selectivity at the molecular target level, so that the index of initial selectivity is greater than 1. The mechanism of the selective action of the biochloramines having significant molecular masses (150-200 Da) probably consists in the inactivation of the molecular target via chemical modification of several reactive atomic groups in its different sites. One may suppose that the biochloramines with lower molecular masses (150-100 Da) exhibit a high anti-aggregatory capacity owing to another mechanism of initial selectivity, which involves the modification of highly sensitive sulfur-containing atomic groups.
authors.forename: D I
authors.initials: DI
authors.lastname: Roshchupkin
authors.forename: M A
authors.initials: MA
authors.lastname: Murina
authors.forename: N N
authors.initials: NN
authors.lastname: Kravchenko
authors.forename: V I
authors.initials: VI
authors.lastname: Sergienko
mesh_terms: D000596:Amino Acids / Q000737:chemistry; D001792:Blood Platelets / Q000187:drug effects*; D002700:Chloramines / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D053657:Platelet-Rich Plasma / Q000187:drug effects
chemical_list: D000596:Amino Acids; D002700:Chloramines; D010975:Platelet Aggregation Inhibitors